Rakovina Therapeutics Inc.
$138,965.00 CAD
≈ 22 months of average Canadian pay
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2022-2023
- Agreement period
- February 1, 2023 – September 30, 2024
- Reference
- nrc-cnrc:172-2022-2023-Q4-1002253
Published purpose
Development of in vitro and in vivo assays to evaluate the membrane permeability, bioavailability and pharmacokinetic profiles of a set of anti-cancer agents.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions